Clinical Development, Regulations and Targeted Protein Degradation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Development

Regulations

Targeted Protein Degradation

Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences

The Pharma Data

JANUARY 31, 2021

Ion channels are a class of integral membrane proteins that regulate the flow of ions across the cell membrane as a means of conducting signals between cells and their environment. . TOKYO and CAMBRIDGE, England , Feb.

Structure Based Drug Design (SBDD)

Structure Based Drug Design (SBDD) Targeted Protein Degradation Drugs Disease

A New Wave of Therapeutic Innovation Through Targeting Transcription Factors

LifeSciVC

FEBRUARY 5, 2025

Substantial biological validation: As transcription factors play central roles in the up-/down-regulation of distinct signaling cascades, we have the ability to look to other pathway regulators, whether that be upstream or downstream, to understand the degree to which a given pathways modulation has on disease.

Small Molecule

Small Molecule Targeted Protein Degradation Regulations Disease

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Drug Discovery Digest

Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences

A New Wave of Therapeutic Innovation Through Targeting Transcription Factors

Webinars

Stay Connected